Company news

Inoviq Ltd news in 2026

Inoviq Ltd's news releases, calls and decks from 2026, newest first.

View company

Addendum to Notice of Annual General Meeting/Proxy Form

November 4, 2026

Initial Director's Interest Notice - A. Chapman

November 1, 2026

IIQ signs EXO-OC validation agreement with Sonic Healthcare

November 1, 2026

IIQ signs EXO-OC validation agreement with Sonic Healthcare

November 1, 2026

Board Changes

October 29, 2026

Quarterly Activities Report and Appendix 4C - September 2026

October 28, 2026

Quarterly Activities Report and Appendix 4C - September 2026

October 28, 2026

INOVIQ receives $1.782m R&D Tax Incentive Refund

October 25, 2026

Notice of Annual General Meeting/Proxy Form

October 22, 2026

INOVIQ Announces Leadership Change

October 22, 2026

EXO-OC Technical Review and Commercialisation Pathway

September 29, 2026

2026 Annual Report

September 16, 2026

Appendix 4G and Corporate Governance Statement

August 26, 2026

Appendix 4E and Preliminary Financial Report

August 26, 2026

Becoming a substantial holder

August 6, 2026

EXO-OC Study Outcome Investor Webinar Presentation

July 13, 2026

Quarterly Activities Report and Appendix 4C - June 2026

July 12, 2026

EXO-OC algorithm and clinical study update

June 30, 2026

Positive CAR-exosome data in ovarian cancer

June 24, 2026

Quarterly Activities Report and Appendix 4C - March 2026

April 27, 2026

Appendix 4D and FY26 Half Year Financial Report

February 17, 2026

Quarterly Business Update and Appendix 4C - December 2025

January 28, 2026

Decks in 2026